At the annual retreat in January, our SLHS Physician Leadership Group approved several important changes that will enable Saint Luke’s Health System to revise its flow of accountability for providing the highest quality care. This flow of accountability is transmitted from the Board of Directors through the medical staff presidents to the general medical staff.
I graduated from the six-year combined BLA-MD program at the University of Missouri – Kansas City in 2005 and completed my general surgery residency through UMKC at Truman Medical Centers and Saint Luke's Hospital in 2010. I am board certified with the American Board of Surgery.
Tissue plasminogen activator (tPA) is one of the most effective treatments for ischemic stroke. Saint Luke’s stroke experts have created RESOLVE, a new tool to help physicians weigh the risks and benefits of tPA administration.